Phenotype: | superoxide dismutase activity decreased efficacy, abnormal |
---|---|
Note: | This statement combines anatomy and/or ontology terms with phenotype quality terms to create a complete phenotype (EQ) statement. For detailed information on individual terms, click the hyperlinked term name. |
Name: | superoxide dismutase activity |
---|---|
Synonyms: | copper, zinc superoxide dismutase activity, Cu,Zn-SOD, Cu-Zn superoxide dismutase activity, cuprein, cytocuprein, erythrocuprein, Fe-SOD, ferrisuperoxide dismutase activity, hemocuprein, hepatocuprein, iron superoxide dismutase activity, iron superoxide oxidoreductase, manganese superoxide dismutase activity, manganese superoxide oxidoreductase, Mn, Fe superoxide dismutase, Mn-SOD, nickel superoxide dismutase activity, nickel superoxide oxidoreductase, SOD, SOD-1, SOD-2, SOD-3, SOD-4, SODF, SODS, superoxide dismutase I, superoxide dismutase II, superoxide:superoxide oxidoreductase activity, zinc superoxide oxidoreductase |
Definition: | Catalysis of the reaction: 2 superoxide + 2 H+ = O2 + hydrogen peroxide. |
Ontology: | GO: Molecular Function [GO:0004784] QuickGO AmiGO |
Name: | decreased efficacy |
---|---|
Synonyms: | |
Definition: | A decrease in the ability of a process to produce its output. |
Ontology: | Phenotypic Quality Ontology [PATO:0015003] |